Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Shares Outstanding (Weighted Average) (2019 - 2025)

Biodesix's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $7.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 16.71% year-over-year to $7.6 million; the TTM value through Dec 2025 reached $7.6 million, up 16.71%, while the annual FY2025 figure was $7.6 million, 16.71% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $7.6 million in Q4 2025 per BDSX's latest filing, up from $7.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $146.7 million in Q2 2025 to a low of $2.5 million in Q2 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $54.1 million, with a median of $37.8 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 10110.78% in 2021, then plummeted 92.12% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $27.4 million in 2021, then soared by 53.86% to $42.1 million in 2022, then skyrocketed by 95.03% to $82.1 million in 2023, then tumbled by 92.12% to $6.5 million in 2024, then rose by 16.71% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Shares Outstanding (Weighted Average) are $7.6 million (Q4 2025), $7.4 million (Q3 2025), and $146.7 million (Q2 2025).